Vol.
30
No.
10
October 26, 2007Oct 26, 2007
Free

Early Clinical Trials Of Targeted Therapies Highlighted At AACR-NCI-EORTC Meeting

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

Flavopiridol Plus Cisplatin Tested In Phase II Trial

Trial Combines Drugs Against Blood Vessel Formation

Bevacizumab And Irinotecan May Increase Survival Of GBM

NCI Cooperative Group, Cancer Center Trials Listed

Login